98 related articles for article (PubMed ID: 25893380)
1. miR-20b is up-regulated in brain metastases from primary breast cancers.
Ahmad A; Ginnebaugh KR; Sethi S; Chen W; Ali R; Mittal S; Sarkar FH
Oncotarget; 2015 May; 6(14):12188-95. PubMed ID: 25893380
[TBL] [Abstract][Full Text] [Related]
2. Role of MicroRNAs in Breast Cancer Metastasis to the Brain: A New Therapeutic Perspective.
Khanegheini B; Ghasemi A; Heidari MA; Aeinfar K; Firoozi S; Tamaddon M; Fereidouni Z
Galen Med J; 2023; 12():1-4. PubMed ID: 38774849
[No Abstract] [Full Text] [Related]
3. Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells.
Burnett RM; Craven KE; Krishnamurthy P; Goswami CP; Badve S; Crooks P; Mathews WP; Bhat-Nakshatri P; Nakshatri H
Oncotarget; 2015 May; 6(14):12682-96. PubMed ID: 25926557
[TBL] [Abstract][Full Text] [Related]
4. EGFR and HER2 signaling in breast cancer brain metastasis.
Sirkisoon SR; Carpenter RL; Rimkus T; Miller L; Metheny-Barlow L; Lo HW
Front Biosci (Elite Ed); 2016 Jan; 8(2):245-63. PubMed ID: 26709660
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog.
Ahmad A; Sayed A; Ginnebaugh KR; Sharma V; Suri A; Saraph A; Padhye S; Sarkar FH
Am J Transl Res; 2015; 7(2):298-308. PubMed ID: 25901198
[TBL] [Abstract][Full Text] [Related]
6. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T
Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542
[TBL] [Abstract][Full Text] [Related]
7. MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brain.
Patil R; Ljubimov AV; Gangalum PR; Ding H; Portilla-Arias J; Wagner S; Inoue S; Konda B; Rekechenetskiy A; Chesnokova A; Markman JL; Ljubimov VA; Li D; Prasad RS; Black KL; Holler E; Ljubimova JY
ACS Nano; 2015 May; 9(5):5594-608. PubMed ID: 25906400
[TBL] [Abstract][Full Text] [Related]
8. Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy.
Murrell DH; Hamilton AM; Mallett CL; van Gorkum R; Chambers AF; Foster PJ
Transl Oncol; 2015 Jun; 8(3):176-84. PubMed ID: 26055175
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer.
Castaneda CA; Flores R; Rojas KY; Castillo M; Dolores-Cerna K; Flores C; Belmar-Lopez C; Milla E; Gomez H
CNS Oncol; 2015; 4(3):137-45. PubMed ID: 25906174
[TBL] [Abstract][Full Text] [Related]
10. MiRNAs as new potential biomarkers and therapeutic targets in brain metastasis.
Beylerli O; Shi H; Begliarzade S; Shumadalova A; Ilyasova T; Sufianov A
Noncoding RNA Res; 2024 Sep; 9(3):678-686. PubMed ID: 38577014
[TBL] [Abstract][Full Text] [Related]
11. New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets.
Hussen BM; Abdullah KH; Abdullah SR; Majeed NM; Mohamadtahr S; Rasul MF; Dong P; Taheri M; Samsami M
Noncoding RNA Res; 2023 Dec; 8(4):645-660. PubMed ID: 37818447
[TBL] [Abstract][Full Text] [Related]
12. Advances in Brain Metastases Diagnosis: Non-coding RNAs As Potential Biomarkers.
Eraky AM
Cureus; 2023 Mar; 15(3):e36337. PubMed ID: 37077610
[TBL] [Abstract][Full Text] [Related]
13. Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines.
Ranapour S; Motamed N
Mol Biotechnol; 2023 Dec; 65(12):1979-1990. PubMed ID: 36905464
[TBL] [Abstract][Full Text] [Related]
14. Melatonin Modulation of Radiation-Induced Molecular Changes in MCF-7 Human Breast Cancer Cells.
Alonso-González C; González-Abalde C; Menéndez-Menéndez J; González-González A; Álvarez-García V; González-Cabeza A; Martínez-Campa C; Cos S
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625825
[TBL] [Abstract][Full Text] [Related]
15. RNA-Binding Macrocyclic Peptides.
Pal S; 't Hart P
Front Mol Biosci; 2022; 9():883060. PubMed ID: 35517859
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as therapeutic targets in breast cancer metastasis.
Pouya FD; Rasmi Y; Gazouli M; Zografos E; Nemati M
Drug Deliv Transl Res; 2022 May; 12(5):1029-1046. PubMed ID: 33987801
[TBL] [Abstract][Full Text] [Related]
17. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer.
Kalinina T; Kononchuk V; Alekseenok E; Obukhova D; Sidorov S; Strunkin D; Gulyaeva L
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33923732
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives.
Watase C; Shiino S; Shimoi T; Noguchi E; Kaneda T; Yamamoto Y; Yonemori K; Takayama S; Suto A
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802424
[TBL] [Abstract][Full Text] [Related]
19. Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets.
Lv Y; Ma X; Du Y; Feng J
Onco Targets Ther; 2021; 14():589-607. PubMed ID: 33519208
[TBL] [Abstract][Full Text] [Related]
20. Microglial Annexin A3 promoted the development of melanoma via activation of hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway.
Xu B; Zhang X; Gao Y; Song J; Shi B
J Clin Lab Anal; 2021 Feb; 35(2):e23622. PubMed ID: 33118214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
